China NMPA Product Recall - Fully Automated Biochemical and Immunological Analyzer

Ortho-Clinical Diagnostics, Inc. has initiated a voluntary Class III recall for its fully automated biochemical and immunoassay analyzer. This action, publicly reported by the National Medical Products Administration (NMPA) on April 23, 2023, addresses a critical operational concern. The manufacturer identified a potential design flaw where the analyzer’s cap opener assembly could inadvertently damage MicroTip reagent kits during routine use. This issue has implications for the reliability and accuracy of diagnostic tests performed using the device. The recall encompasses specific models, specifications, and batch numbers of the analyzer, identified by National Medical Device Registration Certificate No. 20232220063. Comprehensive details regarding the affected products are available in the official "Recall Event Report Form." As a voluntary measure, Ortho-Clinical Diagnostics, Inc. is committed to ensuring product integrity and mitigating any potential risks to patient safety and diagnostic efficacy. The NMPA's involvement, classifying this as a Class III recall, indicates a situation where product use is unlikely to cause adverse health consequences but warrants corrective action. This regulatory oversight ensures that manufacturers address product deficiencies in a structured manner, upholding the quality standards essential for medical devices in China's healthcare system.